Market research
CDMO Avid Bioservices Inc
NASDAQ USD Healthcare
Latest close
As of 05 Mar 2025
Test a moving-average rule with historical data.
Market facts
- Market cap
- 799M
- P/E ratio
- Not available
- Analyst target
- 12.5
- Dividend yield
- Not available
- Beta
- 1.41
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- Not available
- Market cap
- 799M
- P/E ratio
- Not available
- Analyst target
- 12.5
- Dividend yield
- Not available
- Beta
- 1.41
About
About Avid Bioservices Inc
Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.
Research context
Avid Bioservices Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the CDMO discussion.
5 years, 6 months ago
Avid Bioservices, Inc is currently in a long term uptrend where the price is trading 67.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 13.7.
Avid Bioservices, Inc's total revenue rose by 60.5% to $22M since the same quarter in the previous year.
Its net income has increased by 204.9% to $2M since the same quarter in the previous year.
Finally, its free cash flow grew by 191.6% to $2M since the same quarter in the previous year.
Based on the above factors, Avid Bioservices, Inc gets an overall score of 5/5.